InspireMD Completes First Phase Of Manufacturing Consolidation

(RTTNews) - InspireMD, Inc. (NSPR), a provider of embolic protection stents, said it has completed the first phase of a manufacturing consolidation that the company believes would improve its long term gross margins.

Alan Milinazzo, President and CEO of InspireMD, said, "As we prepare to announce the 12-month results from the MASTER trial in October, we continue to put in place the appropriate infrastructure to be able to meet the anticipated increase in demand for our lifesaving stent technology.''

The company also signed an agreement with HealthLink Europe, a medical device support services and distribution company, to provide logistical and customer support for its commercial operations and clinical activities.

HealthLink will provide InspireMD with customer service center capabilities for inquiries from hospitals and distributors. HealthLink will also handle inventory controls, warehousing, shipping and invoicing and receivables management for InspireMD's customers.

Milinazzo added, ''The agreement with HealthLink Europe is intended to support both current commercial activities as well as ongoing clinical trials, and should provide us instant access to world-class customer logistics to support all of our customers through a single partner."